你好,欢迎访问上海交通大学附属第一人民医院公济文库!
导航
语种
  • 任何
  • 9047 中文
  • 156 外文
年代
  • 任何
  • 82 2024
  • 19 2023
  • 101 2022
  • 155 2021
  • 237 2020
  • 255 2019
  • 278 2018
  • 296 2017
  • 284 2016
  • 297 2015
  • 345 2014
  • 376 2013
  • 364 2012
  • 370 2011
  • 346 2010
  • 3371 2000-2009
  • 1242 1990-1999
  • 781 1989以前
科室团队
  • 任何
  • 537 眼科临床医学中心
  • 493 泌尿外科临床医学中心
  • 427 普外科临床医学中心
  • 386 骨科
  • 338 消化科
  •     更多
作者
  • 任何
  • 200 唐孝达
  • 173 谢桐
  • 163 庄心良
  • 150 王兴鹏
  • 126 张皙
  •     更多
文献类型
重要期刊
  • 任何
  • 9203 CSCD中国科学引文库
  • 6226 国内核心期刊
  • 6196 CA化学文摘(美)
  • 6132 国内统计源期刊
  • 2952 文摘杂志(俄)
  •     更多
检索结果:检索 返回 9203 结果。
保存本页
排序:

作者: CAO Ni-da1,ZHU Xiao-hong1,MA Fang-qi1,XU Yan1,DONG Jia-huan1,QIN Meng-meng1,LIU Tian-shu2,ZHU Chun-chao3,GUO Wei-jian4,DING Hong-hua5,GUO Yuan-biao6,LIU Li-kun7,SONG Jin-jie8,WU Ji-ping9,CHENG Yue-lei10,ZENG Lin11,ZHAO Ai-guang11Oncology Department Ⅰ, Longhua Hospital Shanghai University of Traditional Chinese Medicine;2Oncology Department, Zhongshan Hospital, Fudan University;3Gastrointestinal Surgery Department, Renji Hospital, Shanghai Jiaotong University School of Medicine;4Oncology Department, Fudan University Shanghai Cancer Center;5Oncology Department, Shanghai General Hospital, Shanghai Jiaotong University School of Medicine;6Traditional Chinese Medicine Department, Ruijin Hospital, Shanghai Jiaotong University School of Medicine;7Oncology Department, Shanxi Traditional Chinese Medicine Hospital;8Oncology Department, Xiyuan Hospital, China Academy of Chinese Medical Science;9Oncology Department, Yunnan Province Hospital of Traditional Chinese Medicine;10Oncology Department, Shuguang Hospital, Shanghai University of Traditional Chinese Medicine;11Shanghai New Core Biotechnology Co., Ltd.)

出处: Chinese Journal of Integrative Medicine 2024

摘要: Objective:To describe the treatment patterns and survival status of advanced gastric cancer(AGC)in China in the past two decades,and objectively evalu ...

作者: 王钧锋1,刘静2,邓国英11上海市第一人民医院创伤中心;2上海交通大学材料学院)

出处: 中国中西医结合杂志 2024

摘要: 创面特别是复杂创面愈合是一个顽固的临床难题'(1)',目前尚无理想的治疗方法。正常情况下,创面愈合是一个复杂而动态的生理过程,包括四个不同的阶段:止血、炎症、增殖和迁移、组织重塑,涉及炎性细胞浸润、上皮再生、血管生成、肉芽组织形成、胶原蛋白沉积等一系列反应[2]

作者: 黄春梅,王宁,李雪莲,陈兰,陈梦灵,顾陈婕 (上海市第一人民医院护理部)

出处: 中国感染控制杂志 2024

关键词: 医护人员;猴痘; 知识;态度; 影响因素

摘要: 目的 分析医护人员对猴痘的知识水平、意愿及态度的影响因素。方法 采用横断面调查的方法,于2023年1—4月随机抽取上海市某三甲医院医护人员700名,应用自行编制的猴痘调查问卷,通过问卷星进行匿名调查。结果 共回收问卷612份,有效问卷581份,回收率87.43%,有效率94.93%。问卷平均得分为( ...

作者: 邹妮,朱丹,王丹,舒文,王琳,李琴 (上海市第一人民医院院感防控办公室;上海市第一人民医院检验科;上海市第一人民医院临床药学科)

出处: 中国感染控制杂志 2024

关键词: 感染预防控制;抗菌药物管理; 细菌耐药

摘要: 目的 探讨医疗机构应用感染预防控制(IPC)与抗菌药物管理(AMS)的协同模式降低细菌耐药水平的效果。方法 收集某院2015年1月1日—2022年12月31日所有住院患者医院感染管理、抗菌药物相关指标及多重耐药菌(MDRO)检出率,评估IPC联合AMS协同模式的效果。结果 与2015—2016年比较 ...

作者: Fan Yi1,Xu Mimi1,Tu Yuqing1,Hu Yu2,Liu Qifa3,Zhao Weili4,Zhang Xiaohui5,Sun Zimin6,Niu Ting7,Hu Jianda8,Li Juan9,Liu Lin10,Liu Li11,Wang Sanbin12,Gao Sujun13,Lai Yongrong14,Song Xianmin15,Li Zhenyu16,Wang Jingbo17,Jiang Zhongxing18,Xu Yajing19,Yan Jinsong20,He Pengcheng21,Yang Jianmin22,Chen Jia1,Xu Yang1,Huang Xiaojun5,Wu Depei11National Clinical Research Center for Hematologic Diseases, The First Affiliated Hospital of Soochow University, Jiangsu Institute of Hematology, Suzhou, Jiangsu, China;2Department of Hematology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;3Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong, China;4State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, National Research Center for Translational Medicine, Shanghai Rui Jin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;5Department of Hematology, Peking University People’s Hospital, Peking University Institute of Hematology, Peking University, Beijing, China;6Department of Hematology, The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China, Hefei, Anhui, China;7Department of Hematology, West China Hospital, Sichuan University, Chengdu, Sichuan, China;8Department of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, China;9Department of Hematology, The First Affiliated Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China;10Department of Hematology, The First Affiliated Hospital of Chongqing Medical University, Chongqing, China;11Department of Hematology, Tangdu Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China;12Department of Hematology, General Hospital of Kunming Military Region of the People’s Liberation Army (PLA), Kunming, Yunan, China;13Department of Hematology and Oncology, Bethune First Hospital Of Jilin University, Changchun, Jilin, China;14Department of Hematology, The First Affiliated Hospital of Guangxi Medical University, Guilin, Guangxi, China;15Department of Hematology, Shanghai General Hospital, Shanghai, China;16Department of Hematology, The Affiliated Hospital of Xuzhou Medical University, Xuzhou, Jiangsu, China;17Department of Hematology, Aerospace Center Hospital, Beijing, China;18Department of Hematology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China;19Department of Hematology, Xiangya Hospital, Central South University, Changsha, Hunan, China;20Department of Hematology, Second Hospital of Dalian Medical University, Dalian, Liaoning, China;21Department of Hematology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an, Shaanxi, China;22Department of Hematology, Changhai Hospital, Shanghai, China)

出处: 中华医学杂志英文版 2024

作者: Shi Tingyan1,2,Liu Jihong3,Zhu Jianqing4,Wang Xipeng5,Jiang Wei6,Lu Xin6,Feng Weiwei7,Zhou Shengtao8,Shen Yang9,Chen Gang10,Wu Zhenyu11,Zou Dongling12,Wu Peng13,Yang Huijuan14,Wu Sufang15,Zhu Tao4,Wang Huaying14,Zhang Yingli4,Qiu Lihua16,Guo Xiaoqing17,Xiang Libing1,2,Zhang Wei18,19,Ren Yulan14,Feng Yanling3,Liu Yanfei20,Chen Xiaojun21,Zang Rongyu1,21Department of Gynecologic Oncology, Fudan University Zhongshan Hospital;2Institute for Ovarian Cancer, Fudan University, Shanghai, China;3Department of Gynecologic Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong, China;4Department of Gynecologic Oncology, Zhejiang Cancer Hospital, Hangzhou, Zhejiang, China;5Department of Obstetrics and Gynecology, Xinhua Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, China;6Department of Gynecology, Obstetrics and Gynecology Hospital, Fudan University, Shanghai, China;7Department of Obstetrics and Gynecology, Ruijin Hospital, Shanghai Jiaotong University, School of Medicine, Shanghai, China;8Department of Obstetrics and Gynecology, Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE and State Key Laboratory of Biotherapy, West China Second Hospital, Sichuan University and Collaborative Innovation Center, Chengdu, Sichuan, China;9Department of Obstetrics and Gynecology, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu, China;10National Clinical Research Center for Gynecology and Obstetrics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;11School of Public Health, Key Laboratory of Public Health Safety and Collaborative Innovation Center of Social Risks Governance in Health, Fudan University, Shanghai, China;12Gynecologic Oncology Center, Chongqing University Cancer Hospital, Chongqing, China;13Department of Obstetrics and Gynecology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, China;14Department of Gynecologic Oncology, Fudan University Shanghai Cancer Center, Shanghai, China;15Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China;16Department of Obstetrics and Gynecology, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China;17Shanghai Institute of Maternal-Fetal Medicine and Gynecologic Oncology, Shanghai First Maternity and Infant Hospital, School of Medicine, Tongji University, Shanghai, China;18Biomedical Informatics &;19Statistics Center, School of Public Health, Fudan University, Shanghai, China;20Office of Clinical Research, Fudan University Shanghai Cancer Center, Shanghai, China;21Department of Gynecology, the Tenth People’s Hospital of Tongji University, Shanghai, China)

出处: 中华医学杂志英文版 2024

作者: 李璇宇,张治,梁夫友 (上海交通大学船舶海洋与建筑工程学院;上海交通大学医学院上海市第一人民医院)

出处: 医用生物力学 2024

作者: 郭巧梅1,乔理华1,王琳1,王薛庆1,吴飞1,梁小卉1,孙玉腾2,娄加陶11上海市第一人民医院, 上海交通大学医学院附属第一人民医院检验医学中心, 上海;2蚌埠医科大学检验医学院, 蚌埠)

出处: 中华检验医学杂志 2024

关键词: 结节病;肺;腺癌;DNA甲基化

摘要: 目的分析CT表现为结节的肺腺癌患者的组织甲基化特征。方法回顾性研究。收集2022年6月1日至2024年1月20日于上海市第一人民医院确诊为肺腺癌的70例肺结节患者。使用随机数字表法将其分为2组, 发现组40例和验证组30例。发现组中组织样本采用简并亚硫酸氢盐测序技术(RRBS)检测分析, 比较癌组织 ...

作者: 刘子实,李彤,孙晓东 (上海交通大学附属第一人民医院眼科国家眼部疾病临床医学研究中心上海市眼底病重点实验室上海眼视觉与光医学工程技术研究中心)

出处: 中华眼底病杂志 2024

关键词: 遗传性视网膜变性;环磷酸鸟苷;光转导;综述

摘要: 遗传性视网膜变性(IRD)是一组具有高度遗传异质性和临床异质性的眼底病,目前已发现超过300种基因突变与IRD有关。胞内第二信使环磷酸鸟苷(cGMP)的失调在多种IRD的发生和发展中发挥重要作用。cGMP在光感受器细胞中参与光转导过程,当cGMP水平异常增高,则会过度激活蛋白激酶G和环核苷酸门控通道 ...

作者: 丁思洁1,马粤云2,马佳颖31丽水市人民医院肿瘤放化疗科;2上海市第一人民医院放疗科;3丽水市人民医院放射物理室)

出处: 中国微生态学杂志 2024

关键词: 可溶性尿激酶型纤溶酶原激活物受体;葡萄糖调节蛋白78;结肠癌;肠道菌群失调

摘要: 目的 探讨可溶性尿激酶型纤溶酶原激活物受体(suPAR)和葡萄糖调节蛋白78(GRP78)在结肠癌患者血清中的表达及其与肠道菌群失调的相关性。方法 选取我院2020年5月至2023年5月接收的116例结肠癌患者作为结肠癌组,另选同期健康体检者114例作为对照组,采用ELISA法检测两组血清suPAR ...

已保存题录(0)